STAAR Surgical Co reports results for the quarter ended March 31 - Earnings Summary

• STAAR Surgical Co STAA.OQ reported a quarterly adjusted loss of 53 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 9 cents. The mean expectation of thirteen analysts for the quarter was for a loss of 59 cents per share. Wall Street expected results to range from -78 cents to -44 cents per share.

• Revenue fell 44.9% to $42.59 million from a year ago; analysts expected $40.30 million.

• STAAR Surgical Co's reported EPS for the quarter was a loss of $1.10​.

• The company reported a quarterly loss of $54.21 million.

• STAAR Surgical Co shares had risen by 5.7% this quarter and lost 23.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 607.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 10 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

• Wall Street's median 12-month price target for STAAR Surgical Co is $17.00

This summary was machine generated from LSEG data May 7 at 09:06 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)